Dr. Rosalyn Juergens on Managing Acquired Resistance to Targeted Therapies for Advanced NSCLC

Medicine, #acquired, #advanced, #alk, #cancergrace, #driver, #egfr, #grace, #gracecast, #juergens, #mcmaster, #mutaiton, #mutation, #nsclc, #oligometastatic, #rearrangement, #resistance, #rosalyn, #targeted, #therapy, #university